» Articles » PMID: 18436900

A Risk Analysis Method to Evaluate the Impact of a Computerized Provider Order Entry System on Patient Safety

Overview
Date 2008 Apr 26
PMID 18436900
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Quantitative evaluation of safety after the implementation of a computerized provider order entry (CPOE) system, stratification of residual risks to drive future developments.

Design: Comparative risk analysis of the drug prescription process before and after the implementation of CPOE system, according to the Failure Modes, Effects and Criticality Analysis (FMECA) method.

Measurements: The failure modes were defined and their criticality indices calculated on the basis of the likelihood of occurrence, potential severity for patients, and detection probability. Criticality indices of handwritten and electronic prescriptions were compared, the acceptability of residual risks was discussed. Further developments were proposed and their potential impact on the safety was estimated.

Results: The sum of criticality indices of 27 identified failure modes was 3813 for the handwritten prescription, 2930 (-23%) for CPOE system, and 1658 (-57%) with 14 enhancements. The major safety improvements were observed for errors due to ambiguous, incomplete or illegible orders (-245 points), wrong dose determination (-217) and interactions (-196). Implementation of targeted pop-ups to remind treatment adaptation (-189), vital signs (-140), and automatic edition of documents needed for the dispensation (-126) were the most promising proposed improvements.

Conclusion: The impact of a CPOE system on patient safety strongly depends on the implemented functions and their ergonomics. The use of risk analysis helps to quantitatively evaluate the relationship between a system and patient safety and to build a strategy for continuous quality improvement, by selecting the most appropriate improvements to the system.

Citing Articles

Nudging Health Care Providers' Adoption of Clinical Decision Support: Protocol for the User-Centered Development of a Behavioral Economics-Inspired Electronic Health Record Tool.

Richardson S, Dauber-Decker K, Solomon J, Khan S, Barnaby D, Chelico J JMIR Res Protoc. 2023; 12:e42653.

PMID: 36652293 PMC: 9892982. DOI: 10.2196/42653.


Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists.

Skalafouris C, Blanc A, Grosgurin O, Marti C, Samer C, Lovis C Int J Clin Pharm. 2022; 45(2):406-413.

PMID: 36515779 PMC: 10147748. DOI: 10.1007/s11096-022-01505-5.


Application of Failure Mode, Effects, and Criticality Analysis to the Medication-Use Process for Temperature-Sensitive Drugs in a University Hospital.

Sakly H, Chakroun I, Ben Jeddou K Can J Hosp Pharm. 2022; 75(3):159-168.

PMID: 35847468 PMC: 9245412. DOI: 10.4212/cjhp.3121.


Barriers to the Use of Clinical Decision Support for the Evaluation of Pulmonary Embolism: Qualitative Interview Study.

Richardson S, Dauber-Decker K, McGinn T, Barnaby D, Cattamanchi A, Pekmezaris R JMIR Hum Factors. 2021; 8(3):e25046.

PMID: 34346901 PMC: 8374661. DOI: 10.2196/25046.


Parenteral Nutrition Process Management for Newborn and Preterm Infants - A Preliminary Risk Analysis.

Sommer I, Palmero D, Fumeaux C, Bonnabry P, Bouchoud L, Sadeghipour F Ther Clin Risk Manag. 2021; 17:497-506.

PMID: 34093016 PMC: 8169048. DOI: 10.2147/TCRM.S280938.


References
1.
Brennan T, Leape L, Laird N, Hebert L, Localio A, Lawthers A . Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991; 324(6):370-6. DOI: 10.1056/NEJM199102073240604. View

2.
Bates D, Cullen D, Laird N, Petersen L, Small S, Servi D . Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274(1):29-34. View

3.
Bates D, Teich J, Lee J, Seger D, Kuperman G, Maluf N . The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999; 6(4):313-21. PMC: 61372. DOI: 10.1136/jamia.1999.00660313. View

4.
Williams E, Talley R . The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm. 1994; 29(4):331-2, 334-6, 339. View

5.
DeRosier J, Stalhandske E, Bagian J, Nudell T . Using health care Failure Mode and Effect Analysis: the VA National Center for Patient Safety's prospective risk analysis system. Jt Comm J Qual Improv. 2002; 28(5):248-67, 209. DOI: 10.1016/s1070-3241(02)28025-6. View